Search Results - "Nahl, J."

A protracted outbreak of difficult-to-treat resistant Pseudomonas aeruginosa in a haematology unit: a matched case–control study demonstrating increased risk with use of fluoroquinolone by Rice, W., Martin, J., Hodgkin, M., Carter, J., Barrasa, A., Sweeting, K., Johnson, R., Best, E., Nahl, J., Denton, M., Hughes, G.J.

“…Between September 2016 and November 2020, 17 cases of difficult-to-treat resistant Pseudomonas aeruginosa (DTR-PA) were reported in haematology patients at a…”
Get full text

P43 In vitro activity of cefiderocol and comparators against Gram-negative pathogens: ARTEMIS study in the UK by Wareham, D., Attwood, M., Casey, A. L., Coyne, M., Hughes, D., Lister, M., Nahl, J., Perry, J. D., Henriksen, A. Santerre, Longshaw, C.

“…Abstract Objectives Cefiderocol (CFDC) is a novel siderophore cephalosporin approved in Europe for the treatment of infections caused by aerobic Gram-negative…”
Get full text